EUVIMEDEUVIMED entdecken
Crossref

Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab

Ji-Hoon Lim iD, Soon-Hyo Kwon iD, Bark-Lynn Lew iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.16908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Ji-Hoon Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kyung Hee University Hospital at Gang-dong, Kyung Hee University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Purines, Pyrazoles, Sulfonamides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little real‐world experience regarding the use of baricitinib, an oral selective JAK1/JAK2 inhibitor, for treating moderate to severe atopic dermatitis (AD) has been reported.

Methods

This study aimed to assess the overall outcomes in Korean patients with AD treated with baricitinib. All patients with moderate to severe AD treated with baricitinib between June 2021 and June 2022 were included, and their cases were retrospectively analyzed using medical records. Patients with moderate to severe AD, aged ≥18 years who had failed previous therapies, including those who demonstrated unsatisfactory improvement with dupilumab, were prescribed baricitinib. Patients whose follow‐up period was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPurinesPyrazolesSulfonamidesAzetidinesAntibodies, Monoclonal, HumanizedHumansAdolescentAdultRetrospective StudiesTreatment OutcomeSeverity of Illness IndexPruritusDouble-Blind Method

Substanzen

dupilumabbaricitinibPurinesPyrazolesSulfonamidesAzetidinesAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology, Kyung Hee University Hospital at Gang-dong, Kyung Hee University School of Medicine, Seoul, Korea.

ORCID-Profile: Ji-Hoon Lim, Soon-Hyo Kwon, Bark-Lynn Lew

Zitieren

APA

Lim, J. H., Kwon, S. H., & Lew, B. L. (2024). Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab. International Journal of Dermatology. https://doi.org/10.1111/ijd.16908

Vancouver

Lim JH, Kwon SH, Lew BL. Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab. International Journal of Dermatology. 2024. doi:10.1111/ijd.16908

BibTeX
@article{Lim2024,
  author = {Lim, Ji-Hoon and Kwon, Soon-Hyo and Lew, Bark-Lynn},
  title = {Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.16908}
}
Kostenlos starten →